DOCK8 in immune cells: roles and mechanisms - Report - MDSpire

DOCK8 in immune cells: roles and mechanisms

  • By

  • Zixuan Liao

  • Sicheng Luo

  • Weijie Shen

  • Huiru Lv

  • Zekai Xu

  • Li Xu

  • June 16, 2026

  • 0 min

Share

Clinical Report: The Role and Mechanisms of DOCK8 in Immune Cell Function

Overview

DOCK8 is a crucial guanine nucleotide exchange factor that regulates immune cell function by activating Rho family GTPases, particularly Cdc42. Its deficiency leads to a complex immunodeficiency syndrome characterized by increased susceptibility to infections and allergic manifestations.

Background

DOCK8 plays a vital role in both innate and adaptive immunity, influencing T cell migration, B cell signaling, and NK cell activity. Understanding its mechanisms is essential for developing targeted therapies for conditions associated with DOCK8 deficiency, which presents with severe immunological challenges, including recurrent infections and allergic diseases.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • DOCK8 functions as an atypical guanine nucleotide exchange factor, primarily activating Cdc42.
  • It is essential for T cell migration, immunological synapse assembly, and long-term survival.
  • In B cells, DOCK8 fine-tunes BCR signaling and facilitates germinal center reactions.
  • Deficiency in DOCK8 leads to a combined immunodeficiency syndrome with recurrent infections and allergic manifestations.
  • DOCK8 integrates multiple signaling pathways, coordinating immune cell functions and maintaining immune homeostasis.

Clinical Implications

Clinicians should be aware of the critical role of DOCK8 in immune function and the implications of its deficiency. Early diagnosis and management strategies, including potential hematopoietic stem cell transplantation, are essential for improving patient outcomes.

Conclusion

DOCK8 is a key regulator of immune cell function, and its deficiency results in significant clinical challenges. Further research is needed to elucidate its mechanisms and develop targeted interventions.

Related Resources & Content

  1. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee - PMC
  2. Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism | Bone Marrow Transplantation
  3. Reduced toxicity conditioning and a high CD34+ cell dose can achieve full donor chimerism in DOCK8 deficiency - PubMed
  4. Frontiers in Immunology — The role of CD8+ T cells in the immunoregulation of osteoporosis
  5. the pathologist — A New Diagnostic Target in Insulinoma
  6. Journal of Crohn's and Colitis — Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease
  7. Frontiers in Immunology — HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells
  8. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee - PMC
  9. Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism | Bone Marrow Transplantation
  10. Reduced toxicity conditioning and a high CD34+ cell dose can achieve full donor chimerism in DOCK8 deficiency - PubMed

Original Source(s)

Related Content